Mr. Yu Xuefeng will be speaking at the upcoming World Vaccine Congress Asia 2013 about aligning manufacturing strategies to provide a stable supply of affordable vaccines to emerging markets in Asia. He will be evaluating the advantages and challenges of vaccine manufacturing in Asia, as well as sharing on how to maintain quality vaccines at substantially lower prices to meet emerging market needs and how to leverage on innovative manufacturing strategies to improve production efficiencies.
Mr. Yu is currently the Chairman and Chief Executive Officer of Tianjing Cansino Biotechnology, China. Prior to working at Tianjing Cansino Biotechnology, he worked for IBEX Technologies Inc. as a research scientist. He has also held various leadership positions within Sanofi Pasteur, including Director, Corporate platform leader for Bacterial Vaccine Upstream Development and Director of North America Upstream Bioprocess R&D. Mr. Yu received his BSc and MSc from Nakai University, China and obtained his PhD from McGill University.